Australia markets close in 9 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
132.54-0.69 (-0.52%)
At close: 04:00PM EDT
132.54 0.00 (0.00%)
After hours: 04:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,887,100
1,887,100
1,488,700
1,133,500
1,045,900
Cost of revenue
39,700
39,700
23,200
14,300
10,100
Gross profit
1,847,400
1,847,400
1,465,500
1,119,200
1,035,800
Operating expenses
Research development
565,000
565,000
463,800
328,100
275,000
Selling general and administrative
887,600
887,600
752,700
583,300
433,300
Total operating expenses
1,452,600
1,452,600
1,216,500
911,400
708,300
Operating income or loss
394,800
394,800
249,000
207,800
327,500
Interest expense
4,600
4,600
7,100
25,800
32,800
Total other income/expenses net
-58,100
-58,100
-28,000
-80,600
-188,000
Income before tax
332,100
332,100
213,900
101,400
106,700
Income tax expense
82,400
82,400
59,400
11,800
-300,600
Income from continuing operations
249,700
249,700
154,500
89,600
407,300
Net income
249,700
249,700
154,500
89,600
407,300
Net income available to common shareholders
249,700
249,700
154,500
89,600
407,300
Basic EPS
1.97
-
1.61
0.95
4.38
Diluted EPS
1.90
-
1.56
0.92
4.16
Basic average shares
97,225
-
95,800
94,600
93,100
Diluted average shares
100,625
-
98,900
97,900
97,800